Viral Hepatitis

You have full text access to this OnlineOpen article

Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response†‡

  1. Yasuhiro Asahina1,
  2. Kaoru Tsuchiya1,
  3. Masaru Muraoka1,2,
  4. Keisuke Tanaka1,2,
  5. Yuichiro Suzuki1,2,
  6. Nobuharu Tamaki1,
  7. Yoshihide Hoshioka1,
  8. Yutaka Yasui1,
  9. Tomoji Katoh1,
  10. Takanori Hosokawa1,
  11. Ken Ueda1,
  12. Hiroyuki Nakanishi1,
  13. Jun Itakura1,
  14. Yuka Takahashi1,
  15. Masayuki Kurosaki1,
  16. Nobuyuki Enomoto2,
  17. Sayuri Nitta3,
  18. Naoya Sakamoto3,
  19. Namiki Izumi1,§,*

Article first published online: 29 NOV 2011

DOI: 10.1002/hep.24623

Issue

Hepatology

Hepatology

Volume 55, Issue 1, pages 20–29, January 2012

Additional Information

How to Cite

Asahina, Y., Tsuchiya, K., Muraoka, M., Tanaka, K., Suzuki, Y., Tamaki, N., Hoshioka, Y., Yasui, Y., Katoh, T., Hosokawa, T., Ueda, K., Nakanishi, H., Itakura, J., Takahashi, Y., Kurosaki, M., Enomoto, N., Nitta, S., Sakamoto, N. and Izumi, N. (2012), Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response. Hepatology, 55: 20–29. doi: 10.1002/hep.24623

Author Information

  1. 1

    Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, Tokyo, Japan

  2. 2

    First Department of Internal Medicine, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan

  3. 3

    Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan

  1. §

    fax: +81-422-32-9551

*Department of Gastroenterology and Hepatology, Musashino Red Cross Hospital, 1-26-1 Kyonancho 1-26-1, Musashinoshi, Tokyo 180-8610, Japan

  1. †

    Potential conflict of interest: Nothing to report.

  2. ‡

    Supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology and the Japanese Ministry of Welfare, Health and Labor. The funding source had no role in the collection, analysis, or interpretation of the data, or in the decision to submit the article for publication.

  3. §

    fax: +81-422-32-9551

Publication History

  1. Issue published online: 21 DEC 2011
  2. Article first published online: 29 NOV 2011
  3. Accepted manuscript online: 24 AUG 2011 01:53PM EST
  4. Manuscript Accepted: 16 AUG 2011
  5. Manuscript Received: 14 MAY 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (680K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ludmila Prokunina-Olsson, Brian Muchmore, Wei Tang, Ruth M Pfeiffer, Heiyoung Park, Harold Dickensheets, Dianna Hergott, Patricia Porter-Gill, Adam Mumy, Indu Kohaar, Sabrina Chen, Nathan Brand, McAnthony Tarway, Luyang Liu, Faruk Sheikh, Jacquie Astemborski, Herbert L Bonkovsky, Brian R Edlin, Charles D Howell, Timothy R Morgan, David L Thomas, Barbara Rehermann, Raymond P Donnelly, Thomas R O'Brien, A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus, Nature Genetics, 2013, 45, 2, 164

    CrossRef

  2. 2
    Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Toshifumi Tada, Shusuke Kitabatake, Yoshiki Murakami, Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C, Cytokine, 2013,

    CrossRef

  3. 3
    Scott W. Biggins, James Trotter, Jane Gralla, James R. Burton, Kiran M. Bambha, Jennifer Dodge, Megan Brocato, Linling Cheng, Matt McQueen, Lisa Forman, Michael Chang, Igal Kam, Gregory Everson, Richard A. Spritz, Goran Klintmalm, Hugo R. Rosen, Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation, Journal of Hepatology, 2013, 58, 5, 969

    CrossRef

  4. 4
    Susanna Naggie, Anu Osinusi, Antonios Katsounas, Richard Lempicki, Eva Herrmann, Alexander J. Thompson, Paul J. Clark, Keyur Patel, Andrew J. Muir, John G. McHutchison, Joerg F. Schlaak, Martin Trippler, Bhavana Shivakumar, Henry Masur, Michael A. Polis, Shyam Kottilil, Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: Impaired viral kinetics and therapeutic response, Hepatology, 2012, 56, 2
    Direct Link:
  5. 5
    C. Nelson Hayes, Michio Imamura, Hiroshi Aikata, Kazuaki Chayama, Genetics of IL28B and HCV—response to infection and treatment, Nature Reviews Gastroenterology & Hepatology, 2012, 9, 7, 406

    CrossRef

  6. 6
    Christoph T. Berger, Arthur Y. Kim, IL28B Polymorphisms as a Pretreatment Predictor of Response to HCV Treatment, Infectious Disease Clinics of North America, 2012, 26, 4, 863

    CrossRef

  7. You have free access to this content7
    Kazuaki Chayama, C. Nelson Hayes, Michio Imamura, Impact of interleukin-28B genotype on in vitro and in vivo systems of hepatitis C virus replication, Hepatology Research, 2012, 42, 9
    Direct Link:
  8. 8
    Ken Sato, Hiroaki Hashizume, Yuichi Yamazaki, Norio Horiguchi, Satoru Kakizaki, Hitoshi Takagi, Masatomo Mori, Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads, Hepatology Research, 2012, 42, 9
    Direct Link:
View Full Article with Supporting Information (HTML) Get PDF (680K)